Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
World J Urol ; 33(8): 1129-37, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25240535

ABSTRACT

PURPOSE: To determine the impact of preoperative nutritional status on the development of surgical complications following cystectomy using the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP). METHODS: We performed a retrospective review of the NSQIP 2005-2012 Participant Use Data Files. ACS-NSQIP collects data on 135 variables, including pre- and intraoperative data and 30-day postoperative complications and mortality on all major surgical procedures at participating institutions. Preoperative albumin (<3.5 or >3.5 g/dl), weight loss 6 months before surgery (>10 %), and body mass index (BMI) were identified as nutritional variables within the database. The overall complication rate was calculated, and predictors of complications were identified using multivariable logistic regression models. RESULTS: A total of 1,213 patients underwent cystectomy for bladder cancer between 2005 and 2012. The overall 30-day complication rate was 55.1 % (n = 668). While 14.7 % (n = 102) had a preoperative albumin <3.5 g/dL, 3.4 % had >10 % weight loss in the 6 months prior to surgery and the mean BMI was 28 kg/m(2). After controlling for age, sex, medical comorbidities, medical resident involvement, operation year, operative time, and prior operation, only albumin <3.5 g/dl was a significant predictor of experiencing a postoperative complication (p = 0.03). This remained significant when albumin was evaluated as a continuous variable (p = 0.02). CONCLUSIONS: Poor nutritional status measured by serum albumin is predictive of an increased rate of surgical complications following radical cystectomy. This finding supports the importance of preoperative nutritional status in this population and highlights the need for the development of effective nutritional interventions in the preoperative setting.


Subject(s)
Carcinoma, Transitional Cell/surgery , Cystectomy , Malnutrition/epidemiology , Postoperative Complications/epidemiology , Serum Albumin/metabolism , Thinness/epidemiology , Urinary Bladder Neoplasms/surgery , Weight Loss , Black or African American/statistics & numerical data , Aged , Alcohol Drinking/epidemiology , Body Mass Index , Carcinoma, Transitional Cell/epidemiology , Cohort Studies , Comorbidity , Female , Humans , Logistic Models , Male , Malnutrition/ethnology , Middle Aged , Multivariate Analysis , Postoperative Complications/ethnology , Postoperative Complications/metabolism , Retrospective Studies , Risk Factors , Sex Factors , Smoking/epidemiology , Thinness/ethnology , Urinary Bladder Neoplasms/epidemiology , White People/statistics & numerical data
2.
Clin Infect Dis ; 55(2): 189-93, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22491335

ABSTRACT

BACKGROUND: Noroviruses (NoVs) are the most common cause of epidemic gastroenteritis; however, the relative impacts of individual factors underlying severe illness are poorly understood. This report reviews published NoV outbreak reports to quantify hospitalization and mortality rates and assess their relationship with outbreak setting, transmission route, and strain. METHODS: Using a string of terms related to "norovirus" and "outbreak," we 2435 nonduplicate articles identified in PubMed, EMBASE, and Web of Knowledge published between January 1993 and June 2011. Inclusion criteria included outbreaks with a minimum of 2 ill persons with a common exposure and at least 1 reverse-transcription polymerase chain reaction-confirmed case of NoV disease. Univariate analyses were performed, and multivariable models were fitted to estimate the independent effect of each factor. RESULTS: We analyzed 843 NoV outbreaks reported in 233 published articles from 45 countries. Based upon 71724 illnesses, 501 hospitalizations, and 45 deaths, overall hospitalization and mortality rates were 0.54% and 0.06%, respectively. In multivariate analysis, genogroup 2 genotype 4 (GII.4) NoV strains were associated with higher hospitalization (incidence rate ratio [IRR], 9.4; 95% confidence interval [CI], 6.1-14.4; P< .001) and mortality rates (IRR, 3.1; 95% CI, 1.3-7.6; P = .01). Deaths were much more likely to occur in outbreaks occurring in healthcare facilities (IRR, 60; 95% CI, 6-109; P = .01). CONCLUSIONS: Our review suggests that hospitalizations and deaths were more likely in outbreaks associated with GII.4 viruses, independent of other factors, and underscores the importance of developing vaccines against GII.4 viruses to prevent severe disease outcomes.


Subject(s)
Caliciviridae Infections/epidemiology , Caliciviridae Infections/pathology , Disease Outbreaks , Gastroenteritis/epidemiology , Gastroenteritis/pathology , Norovirus/classification , Norovirus/genetics , Caliciviridae Infections/mortality , Caliciviridae Infections/virology , Gastroenteritis/mortality , Gastroenteritis/virology , Genotype , Hospitalization/statistics & numerical data , Humans , Norovirus/isolation & purification , Survival Analysis , Treatment Outcome
3.
Urol Oncol ; 32(1): 32.e1-9, 2014 Jan.
Article in English | MEDLINE | ID: mdl-23434424

ABSTRACT

BACKGROUND: The management of genitourinary malignancies requires a multidisciplinary care team composed of urologists, medical oncologists, and radiation oncologists. A genitourinary (GU) oncology clinical database is an invaluable resource for patient care and research. Although electronic medical records provide a single web-based record used for clinical care, billing, and scheduling, information is typically stored in a discipline-specific manner and data extraction is often not applicable to a research setting. A GU oncology database may be used for the development of multidisciplinary treatment plans, analysis of disease-specific practice patterns, and identification of patients for research studies. Despite the potential utility, there are many important considerations that must be addressed when developing and implementing a discipline-specific database. METHODS AND MATERIALS: The creation of the GU oncology database including prostate, bladder, and kidney cancers with the identification of necessary variables was facilitated by meetings of stakeholders in medical oncology, urology, and radiation oncology at the University of North Carolina (UNC) at Chapel Hill with a template data dictionary provided by the Department of Urologic Surgery at Vanderbilt University Medical Center. Utilizing Research Electronic Data Capture (REDCap, version 4.14.5), the UNC Genitourinary OncoLogy Database (UNC GOLD) was designed and implemented. RESULTS: The process of designing and implementing a discipline-specific clinical database requires many important considerations. The primary consideration is determining the relationship between the database and the Institutional Review Board (IRB) given the potential applications for both clinical and research uses. Several other necessary steps include ensuring information technology security and federal regulation compliance; determination of a core complete dataset; creation of standard operating procedures; standardizing entry of free text fields; use of data exports, queries, and de-identification strategies; inclusion of individual investigators' data; and strategies for prioritizing specific projects and data entry. CONCLUSIONS: A discipline-specific database requires a buy-in from all stakeholders, meticulous development, and data entry resources to generate a unique platform for housing information that may be used for clinical care and research with IRB approval. The steps and issues identified in the development of UNC GOLD provide a process map for others interested in developing a GU oncology database.


Subject(s)
Databases, Factual , Urogenital Neoplasms/diagnosis , Urogenital Neoplasms/therapy , Academic Medical Centers , Electronic Health Records , Humans , Internet , Medical Informatics , Medical Oncology/organization & administration , North Carolina , Program Development , Software , Universities , Urogenital Neoplasms/epidemiology , Urology/organization & administration
4.
PLoS One ; 7(2): e30609, 2012.
Article in English | MEDLINE | ID: mdl-22363453

ABSTRACT

BACKGROUND: A substantial proportion of men who have sex with men (MSM) in the United States remain unvaccinated against hepatitis B. We sought to understand which factors are associated with vaccination among HIV-negative MSM. METHODOLOGY/PRINCIPAL FINDINGS: Data were from a 2010 web-based survey of adult MSM. We calculated the prevalence of self-reported hepatitis B vaccination among 1,052 HIV-negative or HIV-untested men who knew their hepatitis B vaccination status, and used multivariate logistic regression to determine associated factors. 679 (64.5%) MSM reported being vaccinated. Younger men were more likely to report being vaccinated than older men, and there was a significant interaction between age and history of hepatitis B testing. Men with at least some college education were at least 2.1 times as likely to be vaccinated as men with a high school education or less (95% CI = 1.4-3.1). Provider recommendation for vaccination (aOR = 4.2, 95% CI = 2.4-7.4) was also significantly associated with receipt of vaccination. CONCLUSIONS/SIGNIFICANCE: Providers should assess sexual histories of male patients and offer those patients with male sex partners testing for hepatitis infection and vaccinate susceptible patients. There may be particular opportunities for screening and vaccination among older and more socioeconomically disadvantaged MSM.


Subject(s)
HIV Seronegativity , Health Surveys/statistics & numerical data , Hepatitis B/immunology , Homosexuality, Male/statistics & numerical data , Internet , Self Report , Vaccination/statistics & numerical data , Adolescent , Adult , Cohort Studies , Cross-Sectional Studies , Hepatitis B/virology , Hepatitis B virus/immunology , Humans , Male , Risk Factors , United States/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL